Recurrent Extrahepatic Bile Duct Stones as a Late Complication of ERCP in Patients With Coexisting Intra- and Extrahepatic Bile Duct Stones

Last updated: September 14, 2023
Sponsor: Air Force Military Medical University, China
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gall Bladder Disorders

Treatment

N/A

Clinical Study ID

NCT06041113
KY20232281-C-1
  • All Genders

Study Summary

The management of coexisting intrahepatic bile duct (IBD) and extrahepatic bile duct (EBD) stones is complicated and requires a multidisciplinary approach. The long-term clinical outcomes of patients initially treated with endoscopic retrograde cholangiopancreatography (ERCP) EBD stone extraction remain unclear. Investigators conducted a retrospective study of patients with coexisting IBD and EBD to investigate the long-term impact of ERCP on the incidence of recurrent EBD stones and to identify risk factors of recurrence.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • non-gastrointestinal tract reconstruction patients with coexisting IBD and EBD stoneswho underwent ERCP between July 2008 and December 2020 at Xijing Hospital in China

Exclusion

Exclusion Criteria:

  • patients with benign or malignant EBD strictures
  • sclerosing cholangitis
  • suspected choledochal cysts
  • liver cirrhosis
  • parasitic liver diseases
  • long-term biliary drainage with biliary stents or percutaneous tubes
  • without a definitive IBD stone or with a diagnosis of liver calcification asdetermined by imaging review
  • medical records or follow-up information was unavailable

Study Design

Total Participants: 104
Study Start date:
September 01, 2023
Estimated Completion Date:
July 31, 2024

Connect with a study center

  • Xijing Hospital of Digestive Diseases

    Xi'an, Shaanxi 710032
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.